HEADER TRANSFERASE 25-JUL-22 7YL1 TITLE CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH A FRAGMENT MOLECULE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 10,MAPK 10,MAP KINASE P49 3F12,STRESS-ACTIVATED COMPND 5 PROTEIN KINASE 1B,SAPK1B,STRESS-ACTIVATED PROTEIN KINASE JNK3,C-JUN COMPND 6 N-TERMINAL KINASE 3; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK10, JNK3, JNK3A, PRKM10, SAPK1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS JNK3 FRAGMENT CATALYTIC DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.-C.AHN,M.T.H.DUONG REVDAT 2 29-MAY-24 7YL1 1 REMARK REVDAT 1 26-JUL-23 7YL1 0 JRNL AUTH H.-C.AHN,M.T.H.DUONG JRNL TITL CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH A FRAGMENT JRNL TITL 2 MOLECULE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 13406 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 705 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.49 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 REFLECTION IN BIN (WORKING SET) : 757 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.04 REMARK 3 BIN R VALUE (WORKING SET) : 0.2840 REMARK 3 BIN FREE R VALUE SET COUNT : 42 REMARK 3 BIN FREE R VALUE : 0.3720 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2857 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 49 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.80000 REMARK 3 B22 (A**2) : -3.38000 REMARK 3 B33 (A**2) : -2.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.676 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.349 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.248 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.958 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.886 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2941 ; 0.012 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3980 ; 1.605 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 349 ; 6.668 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;37.870 ;24.338 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 535 ;19.800 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;19.053 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 437 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2199 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 7YL1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1300030786. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13406 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 59.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 52.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.55 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.08500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3OY1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MME 550, ETHYLENE GLYCOL, HEPES, REMARK 280 PH 7.25, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.07450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.58000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.99250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.58000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.07450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.99250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 LEU A 3 REMARK 465 HIS A 4 REMARK 465 PHE A 5 REMARK 465 LEU A 6 REMARK 465 TYR A 7 REMARK 465 TYR A 8 REMARK 465 CYS A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 PRO A 12 REMARK 465 THR A 13 REMARK 465 LEU A 14 REMARK 465 ASP A 15 REMARK 465 VAL A 16 REMARK 465 LYS A 17 REMARK 465 ILE A 18 REMARK 465 ALA A 19 REMARK 465 PHE A 20 REMARK 465 CYS A 21 REMARK 465 GLN A 22 REMARK 465 GLY A 23 REMARK 465 PHE A 24 REMARK 465 ASP A 25 REMARK 465 LYS A 26 REMARK 465 GLN A 27 REMARK 465 VAL A 28 REMARK 465 ASP A 29 REMARK 465 VAL A 30 REMARK 465 SER A 31 REMARK 465 TYR A 32 REMARK 465 ILE A 33 REMARK 465 ALA A 34 REMARK 465 LYS A 35 REMARK 465 HIS A 36 REMARK 465 TYR A 37 REMARK 465 ASN A 38 REMARK 465 MET A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 SER A 401 REMARK 465 GLU A 402 REMARK 465 GLU A 403 REMARK 465 LYS A 404 REMARK 465 THR A 405 REMARK 465 LYS A 406 REMARK 465 ASN A 407 REMARK 465 GLY A 408 REMARK 465 VAL A 409 REMARK 465 VAL A 410 REMARK 465 LYS A 411 REMARK 465 GLY A 412 REMARK 465 GLN A 413 REMARK 465 PRO A 414 REMARK 465 SER A 415 REMARK 465 PRO A 416 REMARK 465 SER A 417 REMARK 465 GLY A 418 REMARK 465 ALA A 419 REMARK 465 ALA A 420 REMARK 465 VAL A 421 REMARK 465 ASN A 422 REMARK 465 SER A 423 REMARK 465 SER A 424 REMARK 465 GLU A 425 REMARK 465 SER A 426 REMARK 465 LEU A 427 REMARK 465 PRO A 428 REMARK 465 PRO A 429 REMARK 465 SER A 430 REMARK 465 SER A 431 REMARK 465 SER A 432 REMARK 465 VAL A 433 REMARK 465 ASN A 434 REMARK 465 ASP A 435 REMARK 465 ILE A 436 REMARK 465 SER A 437 REMARK 465 SER A 438 REMARK 465 MET A 439 REMARK 465 SER A 440 REMARK 465 THR A 441 REMARK 465 ASP A 442 REMARK 465 GLN A 443 REMARK 465 THR A 444 REMARK 465 LEU A 445 REMARK 465 ALA A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 THR A 449 REMARK 465 ASP A 450 REMARK 465 SER A 451 REMARK 465 SER A 452 REMARK 465 LEU A 453 REMARK 465 GLU A 454 REMARK 465 ALA A 455 REMARK 465 SER A 456 REMARK 465 ALA A 457 REMARK 465 GLY A 458 REMARK 465 PRO A 459 REMARK 465 LEU A 460 REMARK 465 GLY A 461 REMARK 465 CYS A 462 REMARK 465 CYS A 463 REMARK 465 ARG A 464 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 356 CG HIS A 356 CD2 0.055 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 74 -63.74 -101.06 REMARK 500 ASP A 87 61.96 67.58 REMARK 500 ARG A 97 63.40 37.03 REMARK 500 GLN A 140 -52.21 -135.74 REMARK 500 ARG A 188 -2.31 76.16 REMARK 500 ASP A 189 34.78 -144.19 REMARK 500 ARG A 212 -42.58 -26.36 REMARK 500 THR A 213 -72.55 -99.81 REMARK 500 LYS A 260 127.54 -174.40 REMARK 500 GLU A 299 1.80 -69.75 REMARK 500 ALA A 320 63.26 -156.28 REMARK 500 LEU A 380 23.61 -75.33 REMARK 500 ASP A 381 29.95 -60.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4KKH RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF INHIBITOR-BOUND JNK3 DBREF 7YL1 A 1 464 UNP P53779 MK10_HUMAN 1 464 SEQRES 1 A 464 MET SER LEU HIS PHE LEU TYR TYR CYS SER GLU PRO THR SEQRES 2 A 464 LEU ASP VAL LYS ILE ALA PHE CYS GLN GLY PHE ASP LYS SEQRES 3 A 464 GLN VAL ASP VAL SER TYR ILE ALA LYS HIS TYR ASN MET SEQRES 4 A 464 SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER VAL GLU SEQRES 5 A 464 VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG TYR GLN SEQRES 6 A 464 ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE VAL SEQRES 7 A 464 CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN VAL ALA SEQRES 8 A 464 ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR HIS SEQRES 9 A 464 ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET LYS CYS SEQRES 10 A 464 VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL PHE SEQRES 11 A 464 THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL TYR SEQRES 12 A 464 LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN VAL SEQRES 13 A 464 ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER TYR LEU SEQRES 14 A 464 LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SER SEQRES 15 A 464 ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN ILE SEQRES 16 A 464 VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP PHE SEQRES 17 A 464 GLY LEU ALA ARG THR ALA GLY THR SER PHE MET MET THR SEQRES 18 A 464 PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU VAL SEQRES 19 A 464 ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE TRP SEQRES 20 A 464 SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG HIS LYS SEQRES 21 A 464 ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN TRP ASN SEQRES 22 A 464 LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO GLU PHE SEQRES 23 A 464 MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR VAL GLU SEQRES 24 A 464 ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO LYS LEU SEQRES 25 A 464 PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU HIS ASN SEQRES 26 A 464 LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SER LYS SEQRES 27 A 464 MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER VAL ASP SEQRES 28 A 464 ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP TYR ASP SEQRES 29 A 464 PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE TYR ASP SEQRES 30 A 464 LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU GLU TRP SEQRES 31 A 464 LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER GLU GLU SEQRES 32 A 464 LYS THR LYS ASN GLY VAL VAL LYS GLY GLN PRO SER PRO SEQRES 33 A 464 SER GLY ALA ALA VAL ASN SER SER GLU SER LEU PRO PRO SEQRES 34 A 464 SER SER SER VAL ASN ASP ILE SER SER MET SER THR ASP SEQRES 35 A 464 GLN THR LEU ALA SER ASP THR ASP SER SER LEU GLU ALA SEQRES 36 A 464 SER ALA GLY PRO LEU GLY CYS CYS ARG HET J6F A 501 19 HETNAM J6F 7-HEXYL-3-METHYL-8-SULFANYLIDENE-9H-PURINE-2,6-DIONE FORMUL 2 J6F C12 H18 N4 O2 S FORMUL 3 HOH *49(H2 O) HELIX 1 AA1 PRO A 98 GLN A 100 5 3 HELIX 2 AA2 ASN A 101 VAL A 118 1 18 HELIX 3 AA3 LEU A 153 ILE A 157 1 5 HELIX 4 AA4 ASP A 162 ALA A 183 1 22 HELIX 5 AA5 LYS A 191 SER A 193 5 3 HELIX 6 AA6 ALA A 231 LEU A 236 1 6 HELIX 7 AA7 ASN A 243 HIS A 259 1 17 HELIX 8 AA8 ASP A 267 GLY A 280 1 14 HELIX 9 AA9 CYS A 283 LYS A 288 1 6 HELIX 10 AB1 GLN A 291 GLU A 299 1 9 HELIX 11 AB2 THR A 308 PHE A 313 1 6 HELIX 12 AB3 PRO A 314 PHE A 318 5 5 HELIX 13 AB4 SER A 322 LEU A 340 1 19 HELIX 14 AB5 SER A 349 GLN A 355 1 7 HELIX 15 AB6 HIS A 356 VAL A 361 1 6 HELIX 16 AB7 ASP A 364 GLU A 369 1 6 HELIX 17 AB8 THR A 386 ASN A 400 1 15 SHEET 1 AA1 2 PHE A 48 VAL A 53 0 SHEET 2 AA1 2 SER A 56 LEU A 61 -1 O PHE A 58 N VAL A 51 SHEET 1 AA2 5 TYR A 64 SER A 72 0 SHEET 2 AA2 5 GLY A 76 ASP A 83 -1 O TYR A 82 N GLN A 65 SHEET 3 AA2 5 ARG A 88 SER A 96 -1 O ARG A 88 N ASP A 83 SHEET 4 AA2 5 ASP A 141 GLU A 147 -1 O MET A 146 N ALA A 91 SHEET 5 AA2 5 LEU A 126 PHE A 130 -1 N ASN A 128 O VAL A 145 SHEET 1 AA3 3 ALA A 151 ASN A 152 0 SHEET 2 AA3 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 AA3 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 CRYST1 50.149 71.985 107.160 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019941 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013892 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009332 0.00000